MedPath
HSA Approval

Valsartan Sandoz film coated tablet 160mg

SIN14140P

Valsartan Sandoz film coated tablet 160mg

Valsartan Sandoz film coated tablet 160mg

April 27, 2012

NOVARTIS (SINGAPORE) PTE LTD

SANDOZ SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVARTIS (SINGAPORE) PTE LTD
Licence HolderSANDOZ SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

C09CA03

valsartan

Manufacturer Information

SANDOZ SINGAPORE PTE. LTD.

Siegfried Barbera S.L

Sandoz Private Limited (SPL)

Novartis Farma S.p.A

Active Ingredients

Valsartan

160.00mg

Valsartan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.